Recent advances in combined modality therapy. [PDF]
Oncologist, 2010 Abstract Combined modality therapy emerged from preclinical data showing that carefully chosen drugs could enhance the sensitivity of tumor cells to radiation while having nonoverlapping toxicities. Recent advances in molecular biology involving the identification of cellular receptors, enzymes, and pathways involved in tumor growth and ...
Mierzwa ML +3 more
europepmc +6 more sources
Combined Modality Therapy of Gemcitabine and Radiation [PDF]
The Oncologist, 2005 Abstract Learning Objectives After completing this course, the reader will be able to: List the advantages of combination chemotherapy and radiotherapy. Explain the rationale for doing in vitro research in the radiochemotherapy field.
Pauwels, Bea +3 more
openaire +5 more sources
Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer.
JAMA Oncol, 2018 Importance Combined-modality therapy with chemotherapy and radiation therapy plays a crucial role in the upfront treatment of patients with limited-stage small cell lung cancer (SCLC), but there may be barriers to utilization in the United States ...
Pezzi TA +9 more
europepmc +2 more sources
Targeted radionuclide therapy in combined-modality regimens [PDF]
The Lancet Oncology, 2017 Targeted radionuclide therapy (TRT) is a branch of cancer medicine concerned with the use of radioisotopes, radiolabelled molecules, nanoparticles, or microparticles that either naturally accumulate in or are designed to target tumours. TRT combines the specificity of molecular and sometimes physical targeting with the potent cytotoxicity of ionising ...
Gill, MR, Falzone, N, Du, Y, Vallis, KA
openaire +6 more sources
Editorial: Developing combined modality therapy with mitochondria-targeting strategy [PDF]
Frontiers in Oncology, 2023 Yong Teng, Yong Teng
doaj +2 more sources
Medulloblastoma: Results with combined modality therapy
International Journal of Radiation Oncology*Biology*Physics, 1989 The results of treatment of posterior fossa (PF) medulloblastomas treated at UCSF between 1966 and 1987 were analyzed. 65 patients (pts) were treated postoperatively with craniospinal radiation therapy (CS XRT). The PF dose was 54 Gy. Initially spinal doses of 30-40 Gy, cranial doses of 40-50 Gy were given. Late sequelae were noted.
C. B. Wilson +7 more
openaire +3 more sources
Case Report: Effective management of residual glioblastoma with combined modality therapy [PDF]
Frontiers in OncologyGlioblastoma (GBM) is an aggressive primary brain tumor with a poor prognosis, often characterized by rapid progression and resistance to conventional therapies.
Heng-Jui Chang +5 more
doaj +2 more sources
Treatment of Obstructive Sleep Apnea. Prospects for Personalized Combined Modality Therapy. [PDF]
Ann Am Thorac Soc, 2016 Deacon NL, Jen R, Li Y, Malhotra A.
europepmc +2 more sources
Complete remission of metastatic osteosarcoma using combined modality therapy: a retrospective analysis of unselected patients in China. [PDF]
BMC Cancer, 2021 Xie L +11 more
europepmc +3 more sources
Combined modality therapy for exsudative form of age-related macular degeneration
Biomedical Photonics, 2013 Treatment outcomes in patients with age-related vascular degeneration due to formation of subretinal neovascular membrane (SNM) of two groups: photodynamic therapy (PDT) with Photosens alone (18 patients) and in combination with anti-VEGF therapy with ...
М. V. Budzinskaya +6 more
doaj +4 more sources